Indian markets brace for a crucial week with Q3 earnings from TCS, Infosys, and RIL, alongside key inflation data. Global cues and US tariff verdict to influence investor sentiment. Read more for detailed analysis.
Tata Consultancy Services (TCS), Kotak Mahindra Bank, and other firms will trade ex-dividend, ex-split, and ex-bonus starting January 12. Know the dates and what it means for your investments.
Patna's ambitious underground Heritage Tunnel linking Bihar & Patna Museums moves forward as TBM assembly starts. The 1.5-km pedestrian gallery, set for a 2027 launch, will showcase Bihar's art. Discover the details!
Key US inflation data for December and delayed reports from the 2025 government shutdown set to impact markets. Major bank earnings season kicks off. Full analysis inside.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Investor Chamath Palihapitiya predicts SpaceX won't IPO but will reverse merge into Tesla. Get the details on this bold forecast and what it means for Elon Musk's empire.
Indian primary market gears up for a busy week with one mainboard and five SME IPOs opening for subscription from Jan 12, 2026. Key details on price bands, issue size, and objectives inside.
Gold and silver prices are poised to stay firm next week due to geopolitical tensions and the US Supreme Court's tariff verdict. Analysts see buying opportunities. Read for key targets and data to watch.
Gold futures on MCX jumped 2.25% this week, settling at Rs 1,38,819. Analysts forecast firm prices as traders await a key US tariff decision. Get the latest market insights.
Geopolitical tensions over Iran protests and US intervention threat could propel silver to ₹260,000/kg. Experts analyze MCX and COMEX price outlook for investors.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
After a 170% rally in 2025, silver's record run is set to continue, says Motilal Oswal. Key drivers include industrial demand, supply crunch, and ETF inflows. Read the full analysis.
Geopolitical tensions from Iran protests & potential US intervention drive safe-haven demand. Experts predict gold to open higher, targeting ₹142,000/10g on MCX. Key levels & analysis inside.
Market expert Vijay L Bhambwani advises traders to focus on protecting capital amid geopolitical tensions and Nifty's sharp fall. Key levels for Nifty and Bank Nifty revealed.
Indian markets face a turbulent 2026 start as US tariff uncertainty and global crises pressure indices. Discover how geopolitical risks are impacting investor sentiment and key sectors.
CY2025 saw divergent Indian equity returns: large-caps gained 9%, small-caps fell 9%. FII outflows hit $17.7B. A US-India tariff deal in 2026 is crucial for recovery. Read the full analysis.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Escalating US-Iran tensions spark protests in Tehran and military contingency plans. Indian analysts warn of market volatility and a surge in gold and silver as safe-haven assets. Read more.
Indian stock markets witnessed a broad sell-off last week. Nifty and Sensex fell over 2.5% as US tariff threats and FPI outflows rattled investors. Experts eye Q3 earnings for direction. Read more.
IREDA reports 15.4% YoY profit growth in Q3 FY26. Shares face volatility despite multibagger returns since listing. Analysts weigh in on the stock's future trajectory.
Seven of India's top 10 companies saw a massive Rs 3.63 lakh crore erosion in market value last week as Sensex fell 2.54%. Reliance Industries was the biggest loser. Read the full analysis.
Seven of India's top 10 companies saw a massive ₹3.63 lakh crore market cap drop last week. RIL, HDFC Bank, Airtel led losses amid US tariff fears and Q3 results. Read the full analysis.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
The combined market valuation of India's top 7 most valued firms eroded by Rs 3.63 lakh crore last week, with Reliance Industries suffering the biggest blow. Discover the full impact and analysis here.
Seven of India's top-10 most valued companies saw a massive erosion of Rs 3.63 lakh crore in market capitalisation last week, with Reliance Industries emerging as the biggest laggard. Discover the full list and analysis.
German small investors, wiped out in company restructurings, are fighting for rights to reinvest. Cases like Varta AG highlight a growing conflict between shareholder rights and insolvency law. Read the full story.
Indian metal stocks fell sharply last week, ending a two-week rally. Discover the reasons behind the plunge, from profit-booking to US tariff threats, and what analysts predict for Q3 results.
Investor Michael Burry, of 'The Big Short' fame, reveals bearish bets against Oracle, citing concerns over its debt-fueled AI infrastructure buildout. Discover his market strategy.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
The Q3 FY26 earnings season begins Jan 12 with TCS & HCL Tech. Over 120 firms, including Infosys & HDFC Bank, to report. Get key previews & full schedule here.
Indian stock markets closed lower for the fifth consecutive session. Sensex fell 605 points amid US tariff worries, FII outflows, and pre-earnings caution. Expert analysis and key levels inside.
Indian stock markets closed lower for the fifth consecutive session on January 9. Get key technical levels for Nifty, Bank Nifty, and 3 stock picks from an expert for the coming week.
Indian equities faced a sharp sell-off last week, with 17 Nifty 500 stocks, including Transformers & Rectifiers and Elecon Engineering, falling 10-18%. Geopolitical tensions and US tariff warnings hit sentiment. Read the full analysis.
Dubai's crypto market is maturing in 2026. With $254.3M revenue forecast and clear regulations, experts reveal how smart strategy, not luck, drives sustainable profits in the UAE's booming digital asset scene.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Retail giant Walmart is set to join the prestigious Nasdaq-100 Index on January 20, replacing AstraZeneca. The move follows its switch from NYSE to Nasdaq. Discover what this means for investors.
